C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: The Rotterdam Study

Journal of Clinical Oncology

Volumn 24, Issue 33, 2006, Pages 5216-5222

  Siemes, Claire ^a   Visser, Loes E ^a   Coebergh, Jan Willem W ^a   Splinter, Ted A W ^a   Witteman, Jacqueline C M ^a   Uitterlinden, André G ^a   Hofman, Albert ^a   Pols, Huibert A P ^a   Stricker, Bruno H Ch ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BREAST TUMOR; CHRONIC DISEASE; COLORECTAL TUMOR; GENE FREQUENCY; GENETICS; HAPLOTYPE; INFLAMMATION; LUNG TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOPLASM; NETHERLANDS; PROSPECTIVE STUDY; PROSTATE TUMOR; RISK; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; C-REACTIVE PROTEIN; CHRONIC DISEASE; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; INFLAMMATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; NETHERLANDS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; VARIATION (GENETICS);

EID: 34247155282     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.1381     Document Type: Article

References (21)

1. Coussens LM, Werb Z: Inflammation and cancer. Nature 420:860-867, 2002
2. Balkwill F, Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 357:539-545, 2001
3. Hashimoto K, Ikeda Y, Korenaga D, et al: The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103:1856-1864, 2005
4. Chung YC, Chang YF: Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol 15:369-373, 2003
5. Nikiteas NI, Tzanakis N, Gazouli M, et al: Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: Prognostic implications. World J Gastroenterol 11:1639-1643, 2005
6. Danesh J, Pepys MB: C-reactive protein in healthy and in sick populations. Eur Heart J 21:1564-1565, 2000
7. Danesh J, Wheeler JG, Hirschfield GM, et al: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397, 2004
8. Ito Y, Suzuki K, Tamakoshi K, et al: Colorectal cancer and serum C-reactive protein levels: A case-control study nested in the JACC Study. J Epidemiol 15:S185-S189, 2005 (suppl 2)
9. Il'yasova D, Colbert LH, Harris TB, et al: Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14:2413-2418, 2005
10. Zhang SM, Buring JE, Lee IM, et al: C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 142:425-432, 2005
11. Platz EA, De Marzo AM, Erlinger TP, et al: No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer. Prostate 59:393-400, 2004
12. Erlinger TP, Platz EA, Rifai N, et al: C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585-590, 2004
13. Rifai N, Buring JE, Lee IM, et al: Is C-reactive protein specific for vascular disease in women? Ann Intern Med 136:529-533, 2002
14. Hofman A, Grobbee DE, de Jong PT, et al: Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7:403-422, 1991
15. Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, et al: Dietary assessment in the elderly: Validation of a semiquantitative food frequency questionnaire Eur J Clin Nutr 52:588-596, 1998
16. Van Der Meer IM, De Maat MP, Hak AE, et al: C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: The Rotterdam Study. Stroke 33:2750-2755, 2002
17. Pearson TA, Mensah GA, Alexander RW, et al: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice - A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511, 2003
18. Carlson CS, Aldred SF, Lee PK, et al: Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77:64-77, 2005
19. Kardys I, de Maat MP, Uitterlinden AG, et al: C-reactive protein gene haplotypes and risk of coronary heart disease: The Rotterdam Study Eur Heart J 27:1331-1337, 2006
20. Horton NJ, Laird NM: Maximum likelihood analysis of generalized linear models with missing covariates. Stat Methods Med Res 8:37-50, 1999
21. Ockene IS, Matthews CE, Rifai N, et al: Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444-450, 2001